Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cora N Sternberg

Showing results (141-150 of 357) with videos related to

Pageof 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell CarcinomaCora N Sternberg, Frede Donskov, Naomi B Haas, et al.
BJU International|November 17, 2007
Novel agents for muscle-invasive and advanced urothelial cancerGuru Sonpavde, Robert Ross, Thomas Powles, et al.
European Urology|April 3, 2012
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literatureFabio Calabrò, Peter Albers, Carsten Bokemeyer, et al.
Clinical Genitourinary Cancer|February 15, 2020
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United StatesDaniel J George, Oliver Sartor, Kurt Miller, et al.
Oncology|April 30, 2014
Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal diseaseLinda Cerbone, Rita Van Ginderdeuren, Joost Van den Oord, et al.
Cancer|August 15, 2013
Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trialsMichael T Schweizer, Peng Huang, Michael W Kattan, et al.
European Urology|October 4, 2020
Prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant Prostate Cancer: Any Rise in Prostate-specific Antigen May Require Closer MonitoringFred Saad, Cora N Sternberg, Eleni Efstathiou, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2010
The requirements of a specialist Prostate Cancer Unit: a discussion paper from the European School of OncologyRiccardo Valdagni, Peter Albers, Chris Bangma, et al.
European Urology Oncology|July 6, 2019
Prognostic Association of Prostate-specific Antigen Decline with Clinical Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide in a Randomized Clinical TrialAndrew J Armstrong, Ping Lin, Celestia S Higano, et al.
Prostate Cancer and Prostatic Diseases|May 15, 2020
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancerNeal Shore, Celestia S Higano, Daniel J George, et al.
Pageof 36

Showing results (141-150 of 357) with videos related to

Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell CarcinomaCora N Sternberg, Frede Donskov, Naomi B Haas, et al.
BJU International|November 17, 2007
Novel agents for muscle-invasive and advanced urothelial cancerGuru Sonpavde, Robert Ross, Thomas Powles, et al.
European Urology|April 3, 2012
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literatureFabio Calabrò, Peter Albers, Carsten Bokemeyer, et al.
Clinical Genitourinary Cancer|February 15, 2020
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United StatesDaniel J George, Oliver Sartor, Kurt Miller, et al.
Oncology|April 30, 2014
Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal diseaseLinda Cerbone, Rita Van Ginderdeuren, Joost Van den Oord, et al.
Cancer|August 15, 2013
Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trialsMichael T Schweizer, Peng Huang, Michael W Kattan, et al.
European Urology|October 4, 2020
Prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant Prostate Cancer: Any Rise in Prostate-specific Antigen May Require Closer MonitoringFred Saad, Cora N Sternberg, Eleni Efstathiou, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2010
The requirements of a specialist Prostate Cancer Unit: a discussion paper from the European School of OncologyRiccardo Valdagni, Peter Albers, Chris Bangma, et al.
European Urology Oncology|July 6, 2019
Prognostic Association of Prostate-specific Antigen Decline with Clinical Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide in a Randomized Clinical TrialAndrew J Armstrong, Ping Lin, Celestia S Higano, et al.
Prostate Cancer and Prostatic Diseases|May 15, 2020
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancerNeal Shore, Celestia S Higano, Daniel J George, et al.
Pageof 36